- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Atezolizumab [TECENTRIQ]
Total 754 results
-
Chonnam National University HospitalRoche Pharma AGCompletedLung Neoplasm MalignantKorea, Republic of
-
Immune DesignGenentech, Inc.TerminatedSarcoma | Myxoid/Round Cell Liposarcoma | Liposarcoma | Synovial Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced SarcomaUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedSmall Cell Lung Carcinoma | Hepatocellular Carcinoma | Carcinoma, Non-Small Cell Lung | Urothelial Carcinoma | Triple Negative Breast CarcinomaKorea, Republic of
-
National Taiwan University HospitalRoche Pharma AG; IpsenRecruitingEsophageal Cancer | Metastatic Cancer | Squamous Cell CarcinomaTaiwan
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Canada, France, Italy, Netherlands
-
Hoffmann-La RocheCompleted
-
McGill University Health Centre/Research Institute...Unknown
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungItaly, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala
-
Oslo University HospitalTerminatedNon-small Cell Lung CancerNorway
-
Spanish Oncology Genito-Urinary GroupRoche Farma, S.A; Dynamic Science S.L.Active, not recruiting
-
I-Mab Biopharma US LimitedNo longer availableCancerUnited States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Hoffmann-La RocheWithdrawn
-
Darell BignerGenentech, Inc.; Istari Oncology, Inc.Withdrawn
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Health Pharma Professional ResearchWithdrawnMalignant Pleural Mesothelioma, Advanced | Malignant Pleural Mesothelioma, UnresectableMexico
-
Gulam ManjiGenentech, Inc.; Halozyme TherapeuticsTerminatedStudy Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma (NEOiPANC)Pancreatic Ductal AdenocarcinomaUnited States
-
Hoffmann-La RocheTerminatedSolid TumorUnited States, Spain, Canada, United Kingdom, Denmark, France, Germany, Israel, Italy, Netherlands, Switzerland
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Netherlands, Denmark, Spain, Canada, France
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Turnstone Biologics, Corp.TerminatedHPV-Associated CancersUnited States, Canada
-
Hoffmann-La RocheCompletedSolid CancersUnited States, Belgium, France, Spain
-
Genentech, Inc.Approved for marketing
-
BioLineRx, Ltd.Genentech, Inc.TerminatedAcute Myeloid LeukemiaIsrael, Spain, United States, Czechia, Poland, Slovakia
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
Alain AlgaziGenentech, Inc.RecruitingCarcinoma | Cancer | Head and Neck Cancer | Squamous Cell CarcinomaUnited States
-
Washington University School of MedicineEli Lilly and Company; ImmunityBio, Inc.WithdrawnNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Carcinoma
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.CompletedSolid TumorUnited States, Korea, Republic of, Spain, France
-
Genprex, Inc.RecruitingSmall Cell Lung Cancer Extensive StageUnited States
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, United Kingdom, Belgium, Netherlands
-
Hoffmann-La RocheCompletedLymphomaUnited States, France, Germany, Italy, United Kingdom
-
Institut CurieRoche Pharma AG; Replimune Inc.Not yet recruitingTriple Negative Breast NeoplasmsFrance
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationNot yet recruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical Carcinoma
-
Hoffmann-La RocheTerminated
-
Spanish Lung Cancer GroupCompletedNon-small Cell Lung Cancer Stage IVSpain
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa Associated Lymphoid TissueFrance
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Switzerland, Netherlands, Canada
-
Niguarda HospitalRecruitingCLL TransformationItaly, Switzerland
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
Hoffmann-La RocheCompletedLymphomaPoland, United States, Germany
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
NeoImmuneTechImmune Oncology NetworkTerminatedMelanoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Hoffmann-La RocheRecruiting